With a revenue increase of 22.48% in the second quarter 2026, year on year to cumulative value of $306 million, Vericel's revenue per employee grew on a trailing twelve months basis to $ 769,606, this marks a new company high.
Within the Healthcare sector Employees of 114 other companies have achieved higher revenue per employee. While Vericel's total ranking has deteriorated compared to the previous quarter from 784 to 1161. Vericel has 398 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VCEL Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	22.48 %	30.09 %	23.27 %	16.58 %	20.09 %
Sales per Employee (TTM) $	769,606	733,884	694,118	650,043	625,927
VCEL's Total Ranking	# 1161	# 784	# 720	# 1086	# 351
Seq. Revenue Change	13.2 %	-26.36 %	37.65 %	6.74 %	20.23 %

VCEL Company Profile >> Back to VCEL Efficiency Comparisons >> Compare VCEL Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 20
Healthcare Sector	# 115
Overall Market	# 1161

Revenue per Employee Statistics
High	Average	Low
$ 769,606	$ 346,963	$ 99,611
(Jun 30 2026)		(Mar 31 2015)

Financial Statements
Vericel's Revenue MRQ	$ 77 Millions	Visit VCEL's Income Statement
Vericel's Revenues TTM	$ 306 Millions	Visit VCEL's aggregate revenue growth
What are VCEL's Sales?		Visit VCEL's Sales by Segment

Other Ratios
Vericel's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VCEL's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VCEL's Competitors
Revenue per Employee for VCEL's Suppliers
Revenue per Employee for VCEL's Customers

You may also want to know
VCEL's Sales Growth Rates	VCEL's Pe Price to earnings ratio	VCEL's Receivables Turnover Ratio	VCEL's Stock Quote
VCEL's Net Income Growth Rates	VCEL's Ps Price to Sales ratio	VCEL's Sales per Employee	VCEL's Asset Turnover Ratio
VCEL's Net Margin	VCEL's Pb Price to Book ratio	VCEL's Financial Strength Ratios	VCEL's Dividend Payout Ratio

Date modified: 2026-09-12T19:01:06+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Indivior Pharmaceuticals Inc	1,333,000.00	$ 1,333.000 Million	1,000
Arcutis Biotherapeutics Inc	1,310,680.79	$ 463.981 Million	354
Lantheus Holdings Inc	1,303,724.22	$ 1,555.343 Million	1,193
Cue Biopharma Inc	1,298,413.79	$ 37.654 Million	29
Puma Biotechnology Inc	1,291,865.92	$ 231.244 Million	179
Arvinas Inc	1,287,398.37	$ 316.700 Million	246
Supernus Pharmaceuticals inc	1,273,677.91	$ 830.438 Million	652
Travere Therapeutics Inc	1,189,798.79	$ 591.330 Million	497
Heron Therapeutics Inc	1,183,648.44	$ 151.507 Million	128
Journey Medical Corp	1,175,534.48	$ 68.181 Million	58
Theravance Biopharma inc	1,159,011.11	$ 104.311 Million	90
Corcept Therapeutics Inc	1,138,100.00	$ 830.813 Million	730
Abbvie Inc	1,129,578.95	$ 64,386.000 Million	57,000
Akebia Therapeutics Inc	1,129,175.26	$ 219.060 Million	194
Siga Technologies Inc	1,095,079.92	$ 53.659 Million	49
Biomarin Pharmaceutical Inc	1,057,626.20	$ 3,406.614 Million	3,221
Hims and Hers Health Inc	1,055,894.35	$ 2,578.494 Million	2,442
Assembly Biosciences Inc	1,025,273.97	$ 74.845 Million	73
Sanara Medtech Inc	1,019,592.91	$ 110.116 Million	108
Ptc Therapeutics inc	1,017,915.24	$ 1,008.754 Million	991
Ani Pharmaceuticals Inc	1,008,638.14	$ 978.379 Million	970
Regeneron Pharmaceuticals Inc	1,008,092.15	$ 15,534.700 Million	15,410
Coya Therapeutics Inc	1,002,393.13	$ 8.019 Million	8
Meiragtx Holdings Plc	986,354.84	$ 397.501 Million	403
Evolus Inc	949,440.12	$ 317.113 Million	334
Arrowhead Pharmaceuticals Inc	941,624.47	$ 669.495 Million	711
Scilex Holding Company	929,647.06	$ 31.608 Million	34
Ardelyx inc	922,073.62	$ 450.894 Million	489
The Oncology Institute Inc	916,137.29	$ 587.244 Million	641
Pacira Biosciences inc	900,077.20	$ 746.164 Million	829

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.